Units
Pharmacotherapeutics 1
Unit code: CSB463
Credit points: 12
Information about fees and unit costs
The dispensing and counselling of pharmacotherapies for infectious diseases requires an advanced knowledge, understanding and skills relevant to infectious disease diagnosis, the mechanism of action of pharmacotherapies, public health microbiology. This unit will demonstrate the correct therapeutic use of drugs in the treatment of infectious diseases following a review of their pathophysiologic basis. Additionally, quality use of medicines issues for these pharmacotherapies will be reviewed and reinforced by the use of clinical scenarios.
Availability
| Semester | Available |
|---|---|
| 2013 Semester 2 | Yes |
Sample subject outline - Semester 2 2013
Note: Subject outlines often change before the semester begins. Below is a sample outline.
Rationale
The dispensing and counselling of pharmacotherapies for infectious diseases requires an advanced knowledge, understanding and skills relevant to infectious disease diagnosis, the mechanism of action of pharmacotherapies, public health microbiology, sterility testing, regulation and quality assurance. In Microbiology 1, you gained an excellent foundation in the structure/function, isolation, identification and significance of micro-organisms of pharmaceutical and clinical relevance and were introduced to core concepts in infectious disease diagnosis, public health microbiology, immunology, antimicrobial agents, sterilisation, disinfection, preservation and aseptic technique. This unit will demonstrate the correct therapeutic use of drugs in the treatment of infectious diseases following a review of their pathophysiologic basis. Additionally, quality use of medicines issues for these pharmacotherapies will be reviewed and reinforced by the use of clinical scenarios.
Aims
The aims of this unit are to:
1. Provide you with the knowledge and skills in the key areas of infectious disease diagnosis.
2. Understand the appropriate selection of anti-bacterial and anti-viral drugs for the treatment of infectious diseases.
Objectives
On completion of this unit you should be able to:
1. Informatively and critically discuss the diagnosis of infectious disease states.
2. Integrate your knowledge of human infectious diseases states and the microbial causative agents .
3. Discuss the pathophysiology of infectious diseases and their management.
4. Describe the treatment of infectious diseases including quality use of medicines issues and the role of the pharmacist in maximizing health outcomes for the patient.
Content
Topics for this unit include:
· The pathophysiology of diseases of bacterial, viral, fungal and parasitic origin.
· Anti-bacterial, anti-viral drugs anti-fungal and anti-protozoic drugs.
· Infectious disease control and prevention, mechanisms of antibiotic resistance.
· Quality use of medicines issues relating to anti-bacterial, anti-viral, antifungal and anti-protozoic drugs.
Approaches to Teaching and Learning
Three hours of face-to-face lectures and two hours of tutorial sessions per week.
Assessment
You will be expected to undertake a number of assessments related to the learning outcomes of this unit (see below).You will be provided with feedback throughout the semester.
Assessment name:
Examination (written)
Description:
Summative. Covers material presented in lectures and tutorial classes, weeks 6 - 13. Questions will be of the short answer/essay type.
Relates to objectives:
1, 2, 3 and 4.
Weight:
40%
Internal or external:
Internal
Group or individual:
Individual
Due date:
Week 12
Assessment name:
Examination (written)
Description:
Summative.
Relates to objectives:
1, 2, 3 and 4.
Weight:
20%
Internal or external:
Internal
Group or individual:
Individual
Due date:
Week 8
Assessment name:
Quiz/Test
Description:
Formative and Summative: Covers material presented in lectures which are further discussed in the tutorial environment.
Quiz will be comprised of two parts: multiple-choice questions and short essay.
Weight: 10% in total i.e. 5% each
Relates to objectives:
1, 2, 3 and 4.
Weight:
10%
Internal or external:
Internal
Group or individual:
Individual
Due date:
Weeks 4 and 10
Assessment name:
Assignment
Description:
Summative.
Relates to objectives:
3 and 4.
Weight:
20%
Internal or external:
Internal
Group or individual:
Individual
Due date:
Week 12
Assessment name:
Viva voce
Description:
Summative: Covers lecture material from weeks 1 -13.
Relates to objectives:
3 and 4.
Weight:
10%
Internal or external:
Internal
Group or individual:
Individual
Due date:
Week 10
Academic Honesty
QUT is committed to maintaining high academic standards to protect the value of its qualifications. To assist you in assuring the academic integrity of your assessment you are encouraged to make use of the support materials and services available to help you consider and check your assessment items. Important information about the university's approach to academic integrity of assessment is on your unit Blackboard site.
A breach of academic integrity is regarded as Student Misconduct and can lead to the imposition of penalties.
Resource materials
DiPiro JT et al (editors) (2008) Pharmacotherapy: A pathophysiologic approach, 6th edition, New York: McGraw-Hill Medical Pub Division.
Risk assessment statement
Pharmacotherapeutics 1 consists of classroom-based lectures and optional tutorials both of which have been assessed as low risk activities.
Disclaimer - Offer of some units is subject to viability, and information in these Unit Outlines is subject to change prior to commencement of semester.
Last modified: 26-Sep-2012
